Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohns disease on combination therapy (SPARE): A multicentre, open-label, randomised controlled trial
GLP-1 receptor agonists, a class of medications used to treat Type 2 diabetes and obesity, are known to slow gastric emptying
Rare cases of Stevens-Johnsons syndrome have been reported with sitagliptin
however, no significant effects were observed on serum TC and lipoprotein levels
If you find that your side effects are too intense, your dedicated team of specialists is available 24/7 to discuss a dosage adjustment or provide specific guidance on managing your symptoms
For compounded formulations specifically, check out our guide on how long compounded semaglutide lasts in refrigerated storage